gamma-aminobutyric acid has been researched along with Cardiovascular Stroke in 12 studies
gamma-Aminobutyric Acid: The most common inhibitory neurotransmitter in the central nervous system.
gamma-aminobutyric acid : A gamma-amino acid that is butanoic acid with the amino substituent located at C-4.
| Excerpt | Relevance | Reference |
|---|---|---|
| "In patients with diabetic neuropathy who were prescribed gabapentin and pregabalin, there is an increased risk for heart failure, myocardial infarction, peripheral vascular disease, stroke, deep venous thrombosis, and pulmonary embolism with long-term use." | 4.12 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "Gabapentin and pregabalin are commonly prescribed medications to treat pain in patients with diabetic neuropathy." | 4.12 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| "The effect of nimodipine, mexidol, melatonin, afobazole, 5-hydroxy-adanamtan-2-one, and GABA conjugates with arachidonic acid and docosahexaenoyl dopamine on the cerebral circulation has been studied in intact rats and those with global transient cerebral ischemia, experimental myocardial infarction, and combined vascular pathology of brain and heart." | 3.80 | [Cerebrovascular pharmacology of separate and combined vascular pathology of brain and heart]. ( Gan'shina, TS; Gnezdilova, AV; Gorbunov, AA; Khaĭlov, NA; Kurdiumov, IN; Lebedeva, MA; Maslennikov, DV; Mirzoian, RS, 2014) |
| " However, whether long-term use of gabapentin and pregabalin is associated with adverse cardiovascular diseases remains unknown." | 1.72 | Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy. ( Blankfield, RP; Davis, PB; Kaebler, DC; Pan, Y; Xu, R, 2022) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 3 (25.00) | 18.7374 |
| 1990's | 1 (8.33) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (50.00) | 24.3611 |
| 2020's | 2 (16.67) | 2.80 |
| Authors | Studies |
|---|---|
| Pan, Y | 1 |
| Davis, PB | 1 |
| Kaebler, DC | 1 |
| Blankfield, RP | 1 |
| Xu, R | 1 |
| Gao, M | 1 |
| Yin, D | 1 |
| Chen, J | 1 |
| Qu, X | 1 |
| Mirzoian, RS | 1 |
| Gan'shina, TS | 1 |
| Khaĭlov, NA | 1 |
| Gnezdilova, AV | 1 |
| Maslennikov, DV | 1 |
| Kurdiumov, IN | 1 |
| Lebedeva, MA | 1 |
| Gorbunov, AA | 1 |
| Liepinsh, E | 2 |
| Makrecka-Kuka, M | 2 |
| Kuka, J | 2 |
| Vilskersts, R | 1 |
| Makarova, E | 1 |
| Cirule, H | 2 |
| Loza, E | 1 |
| Lola, D | 1 |
| Grinberga, S | 2 |
| Pugovics, O | 1 |
| Kalvins, I | 1 |
| Dambrova, M | 2 |
| Li, J | 1 |
| Zhang, MM | 1 |
| Tu, K | 1 |
| Wang, J | 1 |
| Feng, B | 1 |
| Zhang, ZN | 1 |
| Lei, J | 1 |
| Li, YQ | 1 |
| Du, JQ | 1 |
| Chen, T | 1 |
| Pandit, S | 1 |
| Jo, JY | 1 |
| Lee, SU | 1 |
| Lee, YJ | 1 |
| Lee, SY | 2 |
| Ryu, PD | 2 |
| Lee, JU | 1 |
| Kim, HW | 1 |
| Jeon, BH | 1 |
| Park, JB | 1 |
| Sevostjanovs, E | 1 |
| Lee, CH | 1 |
| Hwang, IK | 1 |
| Choi, JH | 1 |
| Yoo, KY | 1 |
| Han, TH | 1 |
| Park, OK | 1 |
| Won, MH | 1 |
| Meerson, FZ | 2 |
| Pavlova, VI | 1 |
| Iakushev, VS | 1 |
| Sinitsyn, SP | 1 |
| Galenko-Iaroshevskiĭ, PA | 1 |
| Medvedev, OS | 1 |
| Uvarov, AV | 1 |
| Mingalev, AN | 1 |
| Turovaia, AIu | 1 |
| Tiukhteneva, ZI | 1 |
| Abdikaliev, NA | 1 |
| Shabunina, EV | 1 |
| Sidhu, HS | 1 |
| Munoz, DG | 1 |
| Wood, JD | 1 |
12 other studies available for gamma-aminobutyric acid and Cardiovascular Stroke
| Article | Year |
|---|---|
Cardiovascular risk of gabapentin and pregabalin in patients with diabetic neuropathy.
Topics: Amines; Analgesics; Cardiovascular Diseases; Cyclohexanecarboxylic Acids; Diabetic Neuropathies; Gab | 2022 |
Activating the interleukin-6-Gp130-STAT3 pathway ameliorates ventricular electrical stability in myocardial infarction rats by modulating neurotransmitters in the paraventricular nucleus.
Topics: Action Potentials; Animals; Cytokine Receptor gp130; Disease Models, Animal; gamma-Aminobutyric Acid | 2020 |
[Cerebrovascular pharmacology of separate and combined vascular pathology of brain and heart].
Topics: Adamantane; Animals; Animals, Outbred Strains; Benzimidazoles; Bicuculline; Cerebral Cortex; Dopamin | 2014 |
Inhibition of L-carnitine biosynthesis and transport by methyl-γ-butyrobetaine decreases fatty acid oxidation and protects against myocardial infarction.
Topics: Animals; Biological Transport; Carnitine; Dose-Response Relationship, Drug; Fatty Acids; gamma-Amino | 2015 |
The excitatory synaptic transmission of the nucleus of solitary tract was potentiated by chronic myocardial infarction in rats.
Topics: Amines; Analgesics; Animals; Cyclohexanecarboxylic Acids; Disease Models, Animal; Excitatory Postsyn | 2015 |
Enhanced astroglial GABA uptake attenuates tonic GABAA inhibition of the presympathetic hypothalamic paraventricular nucleus neurons in heart failure.
Topics: Action Potentials; Animals; Astrocytes; Disease Models, Animal; GABA Plasma Membrane Transport Prote | 2015 |
Decrease in Long-Chain Acylcarnitine Tissue Content Determines the Duration of and Correlates with the Cardioprotective Effect of Methyl-GBB.
Topics: Animals; Betaine; Biotransformation; Cardiotonic Agents; Carnitine; Down-Regulation; gamma-Aminobuty | 2017 |
Calcium binding proteins immunoreactivity in the rat basolateral amygdala following myocardial infarction.
Topics: Amygdala; Animals; Biomarkers; Brain Mapping; Calbindin 2; Calbindins; Calcium-Binding Proteins; Dep | 2010 |
[Activation of GABA system metabolism in the cerebral hemispheres during exposure to different stress factors].
Topics: 4-Aminobutyrate Transaminase; Animals; Aortic Valve Stenosis; Brain; Brain Chemistry; Formaldehyde; | 1981 |
[Effect of the gamma-aminobutyric acid derivative, TZ-50-2, on the systemic and cardiac hemodynamics, and the size of myocardial necrosis area].
Topics: Animals; Anti-Arrhythmia Agents; Cats; Coronary Circulation; GABA Agonists; gamma-Aminobutyric Acid; | 1998 |
[Elimination of disorders in the electrical stability of the heart during postinfarct cardiosclerosis by using a factor that induces GABA accumulation in the brain].
Topics: Animals; Anti-Arrhythmia Agents; Arrhythmias, Cardiac; Brain; Drug Evaluation, Preclinical; Electroc | 1989 |
gamma-Aminobutyric acid (GABA) uptake systems in human frontal cortex.
Topics: Aged; Animals; Biological Transport; Cerebral Cortex; Female; gamma-Aminobutyric Acid; Humans; Kinet | 1987 |